These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29696025)

  • 1. Adrenergic Signaling at the Interface of Allergic Asthma and Viral Infections.
    Ağaç D; Gill MA; Farrar JD
    Front Immunol; 2018; 9():736. PubMed ID: 29696025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral infections and asthma: an inflammatory interface?
    Oliver BG; Robinson P; Peters M; Black J
    Eur Respir J; 2014 Dec; 44(6):1666-81. PubMed ID: 25234802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β2-Adrenoceptor Function in Asthma.
    Amrani Y; Bradding P
    Adv Immunol; 2017; 136():1-28. PubMed ID: 28950943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic neural signaling via the β2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8(+) T-cell effector function.
    Estrada LD; Ağaç D; Farrar JD
    Eur J Immunol; 2016 Aug; 46(8):1948-58. PubMed ID: 27222010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Responses in Rhinovirus-Induced Asthma Exacerbations.
    Steinke JW; Borish L
    Curr Allergy Asthma Rep; 2016 Nov; 16(11):78. PubMed ID: 27796793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.
    Esquivel A; Busse WW; Calatroni A; Togias AG; Grindle KG; Bochkov YA; Gruchalla RS; Kattan M; Kercsmar CM; Khurana Hershey G; Kim H; Lebeau P; Liu AH; Szefler SJ; Teach SJ; West JB; Wildfire J; Pongracic JA; Gern JE
    Am J Respir Crit Care Med; 2017 Oct; 196(8):985-992. PubMed ID: 28608756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies to reduce asthma exacerbations.
    O'Byrne PM
    J Allergy Clin Immunol; 2011 Aug; 128(2):257-63; quiz 264-5. PubMed ID: 21531015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR2 activation causes tachyphylaxis to β2 -agonists in vitro and ex vivo: modelling bacterial exacerbation.
    Alkhouri H; Rumzhum NN; Rahman MM; FitzPatrick M; de Pedro M; Oliver BG; Bourke JE; Ammit AJ
    Allergy; 2014 Sep; 69(9):1215-22. PubMed ID: 24862376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model.
    Rochlitzer S; Hoymann HG; Müller M; Braun A;
    Clin Sci (Lond); 2014 Jan; 126(1):55-65. PubMed ID: 23822145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhinovirus-induced exacerbations of asthma: How is the {beta}2-adrenoceptor implicated?
    Trian T; Moir LM; Ge Q; Burgess JK; Kuo C; King NJ; Reddel HK; Black JL; Oliver BG; McParland BE
    Am J Respir Cell Mol Biol; 2010 Aug; 43(2):227-33. PubMed ID: 19783788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of transcriptional responses by poly(I:C) and human rhinovirus: effect of long-acting β₂-adrenoceptor agonists.
    Rider CF; Miller-Larsson A; Proud D; Giembycz MA; Newton R
    Eur J Pharmacol; 2013 May; 708(1-3):60-7. PubMed ID: 23523474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.
    Elenkov IJ; Wilder RL; Chrousos GP; Vizi ES
    Pharmacol Rev; 2000 Dec; 52(4):595-638. PubMed ID: 11121511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
    Kume H; Fukunaga K; Oguma T
    Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of beta2-agonist: key focus on signaling pathways.
    Bhatnagar P; Guleria R; Kukreti R
    Pharmacogenomics; 2006 Sep; 7(6):919-33. PubMed ID: 16981850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.
    Ortega VE
    Clin Genet; 2014 Jul; 86(1):12-20. PubMed ID: 24641588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing face of β2-adrenergic and muscarinic receptor therapies in asthma.
    Wasilewski NV; Lougheed MD; Fisher JT
    Curr Opin Pharmacol; 2014 Jun; 16():148-56. PubMed ID: 24922602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine Inhibits Th17 Cells via β2-Adrenergic Receptor (β2-AR) Signaling in a Mouse Model of Rheumatoid Arthritis.
    Liu Y; Rui XX; Shi H; Qiu YH; Peng YP
    Med Sci Monit; 2018 Feb; 24():1196-1204. PubMed ID: 29485127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.